| When treating patients with multiple cardiometabolic risk factors, what is your highest priority? |
|
- Obesity
- Hyperglycemia
- C-Reactive Protein
|
 |
| What do you find most difficult to treat? |
|
|
 |
| Which of these emerging new concepts do you think will be the most beneficial to your patients? |
- Direct renin inhibition
- Endocannabinoid system inhibition
- Incretin agents (DPP-4 inhibitors and GLP-1 agonists)
|
- Raising high density lipoproteins (HDL)
- Renin angiotensin aldosterone system (RAAS) inhibition
- Bariatric surgery
|
 |
| When treating your patients with multiple cardiometabolic risk factors, which guidelines do you tend to follow? |
- Adult Treatment Panel III (ATP III)
- JNC VII guidelines
- AHA/ACC guidelines
|
- ADA guidelines
- None of the above, there is a clear need for guidelines for treating these patients
|
 |